CBD News: Industry to FDA: No evidence of liver disease or elevated liver function in CBD study participants

Early results of an industry-sponsored, human-safety study on hemp-derived CBD consumption show no evidence of liver toxicity or disease in its 839 participants.

Industry to FDA: No evidence of liver disease or elevated liver function in CBD study participants is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs



From Industry to FDA: No evidence of liver disease or elevated liver function in CBD study participants on CBD Products & CBD Business News – Hemp Industry Daily.

This was autoposted by IFTTT. To find out more, read my post about news articles.


No comments:

Post a comment

Popular Posts This Week